Essex Investment Management CO LLC Eagle Pharmaceuticals, Inc. Transaction History

Essex Investment Management CO LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Oct 16, 2018	SELL	$66.65 - $83.86 $1.51 Million - $1.9 Million	-22,636 Closed	0 $0
Q2 2018 Jul 17, 2018	BUY	$51.25 - $76.62 $102 - $153	2 Added 0.01%	22,636 $1.71 Million
Q1 2018 Apr 26, 2018	SELL	$52.16 - $66.86 $120,020 - $153,844	-2,301 Reduced 9.23%	22,634 $1.19 Million
Q4 2017 Feb 05, 2018	BUY	$49.6 - $60.87 $33,232 - $40,782	670 Added 2.76%	24,935 $1.33 Million
Q3 2017 Oct 30, 2017	BUY	$46.62 - $60.36 $1.13 Million - $1.46 Million	24,265	24,265 $1.45 Million

8.58M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $11.7M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Essex Investment Management CO LLC, based on Form 13F filings with the SEC.

Stay updated on Essex Investment Management CO LLC with notifications on news.